Promoting social responsibility in the healthcare sector ­

 

Our Correspondent / EMIRATES BUSINESS

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects like the initiative ‘Making More Health’ while also caring for employees.
Respect, equal opportunity and reconciling career and family from the foundation of mutual cooperation. The company also focusses on environmental protection and sustainability in everything it does.
Karim El Alaoui, Managing Director and Head of Prescription Medicine of Boehringer Ingelheim META said, “The UAE has become the regional headquarters for some of the biggest multinational companies in the world as well as an attractive place for small and medium enterprises. The country’s robust infrastructure, structured regulatory and healthcare system as well as being a prime destination for international talent has ensured business’s continued success. To that extent, our new office in Dubai reflects our growing commitment to the country and the wider region as a whole.”
“Patients are at the core of everything we do at Boehringer Ingelheim, and we look forward to building on our established portfolio with an innovative pipeline of medicines across a number of therapeutic areas,” he said.
In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion Euros and R&D expenditure corresponded to 20.3 percent of net sales. Boehringer Ingelheim Middle East and North Africa (MENA) achieved a sales growth of 26 percent. Moreover, the company’s META operations achieved a growth of 17.4 percent in its sales, where strong performing markets included Saudi Arabia, Turkey, Algeria as well as the UAE. In the UAE, Boehringer Ingelheim recorded a 34 percent growth compared to the previous financial year. It also expanded by 65 percent in terms of number of employees in the UAE within the last four years.
The company’s Middle East, Turkey and Africa (META) headquarter is now located in Index Tower, Dubai International Financial Center (DIFC) amid ambitious expansion plans across the UAE and the wider region.